Results
1 -
10 of
85Ulrike Grienke, Michaela Schmidtke, Susanne von Grafenstein, Johannes Kirchmair, Klaus R. Liedl and Judith M. Rollinger.
Influenza neuraminidase: A druggable target for natural products, Nat. Prod. Rep., 2012, 29, 11. Yeng-Tseng Wang.
Insights from modelling the 3D structure of the 2013 H7N9 influenza A virus neuraminidase and its binding interactions with drugs, Med. Chem. Commun., 2013, . Antiviral Drugs for the Treatment and Prevention of Influenza, Current Treatment Options in Infectious Diseases Antiviral Resistance in Influenza Viruses: Clinical and Epidemiological Aspects, Antimicrobial Drug Resistance Japanese Surveillance Systems and Treatment for Influenza, Current Treatment Options in Infectious Diseases In vitro activity of favipiravir and neuraminidase inhibitor combinations against oseltamivir-sensitive and oseltamivir-resistant pandemic influenza A (H1N1) virus, Archives of Virology New treatments for influenza, BMC Medicine PMDA: labelling updates proposed for several products, Reactions Weekly The Bright Side of Bird Flu, Pharmaceutical & Diagnostic Innovation In-silico structural analysis of the influenza A subtype H7N9 neuraminidase and molecular docking with different neuraminidase inhibitors, VirusDisease